Literature DB >> 15978719

Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).

Rajeev S Samant1, Michael T Debies, Douglas R Hurst, Blake P Moore, Lalita A Shevde, Danny R Welch.   

Abstract

The murine ortholog (Brms1) of human breast cancer metastasis suppressor 1 shares 95% identity to the human metastasis suppressor, BRMS1, in amino acid structure. We tested Brms1 for suppression of metastasis of mouse mammary carcinoma cell line 4T1 in syngenic BALB/c mice, using orthotopic (mammary fat pad) injection as well as intravenous injection. As observed for BRMS1, transfection with Brms1 did not inhibit 4T1 primary tumor formation, but significantly suppressed lung colonization. We also show that Brms1 protein interacts with histone deacetylases, indicating involvement of Brms1 in murine Sin3-HDAC complex, like its human counterpart. Thus, because of similarities with its human ortholog, the results suggest that Brms1 will be useful as a model for studying mechanism of action of BRMS1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978719     DOI: 10.1016/j.canlet.2005.04.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.

Authors:  Thomas M Bodenstine; Kedar S Vaidya; Aimen Ismail; Benjamin H Beck; Leah M Cook; Anne R Diers; Aimee Landar; Danny R Welch
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

Review 2.  Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  FEBS Lett       Date:  2011-08-05       Impact factor: 4.124

3.  Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone.

Authors:  Douglas R Hurst; Alka Mehta; Blake P Moore; Pushkar A Phadke; William J Meehan; Mary Ann Accavitti; Lalita A Shevde; James E Hopper; Yi Xie; Danny R Welch; Rajeev S Samant
Journal:  Biochem Biophys Res Commun       Date:  2006-08-10       Impact factor: 3.575

4.  Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.

Authors:  Leah M Cook; Xuemei Cao; Alexander E Dowell; Michael T Debies; Mick D Edmonds; Benjamin H Beck; Robert A Kesterson; Renee A Desmond; Andra R Frost; Douglas R Hurst; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2012-01-13       Impact factor: 5.150

Review 5.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

6.  Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors.

Authors:  T K Das; J Sangodkar; N Negre; G Narla; R L Cagan
Journal:  Oncogene       Date:  2012-08-13       Impact factor: 9.867

7.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Authors:  Pushkar A Phadke; Kedar S Vaidya; Kevin T Nash; Douglas R Hurst; Danny R Welch
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

8.  Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression.

Authors:  Patricia J Champine; Jacob Michaelson; Bart C Weimer; Danny R Welch; Daryll B DeWald
Journal:  Clin Exp Metastasis       Date:  2007-09-25       Impact factor: 5.150

Review 9.  The role of metastasis suppressor genes in metastatic dormancy.

Authors:  Christine E Horak; Jong Heun Lee; Jean-Claude Marshall; S Martin Shreeve; Patricia S Steeg
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

10.  Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.

Authors:  Philip W Smith; Yuan Liu; Suzanne A Siefert; Christopher A Moskaluk; Gina R Petroni; David R Jones
Journal:  Cancer Lett       Date:  2008-12-25       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.